The Nasdaq edged up while the Dow dipped early Friday after the December US employment report showed somewhat slower job growth but an uptick in wages.
The US economy added a solid 156,000 jobs in December, slightly below analyst expectations. However, the Labor Department report also upgraded the job estimate for November and said average hourly earnings rose to $26.00, up 10 cents from the prior month.
“The key takeaway from the report is that job growth is slowing while wages are rising, which are offshoots of a labor market running near full employment,” Briefing.com analyst Patrick O’Hare said.
The broad-based S&P 500 shed 0.1 percent to 2,266.33, while the tech-rich Nasdaq Composite Index advanced 0.1 percent to 5,494.52.
Navient Corp (NASDAQ:NAVI), with shares high 2.33% is now trading at $16.90. The Stock is active as 1.00M shares changed hands versus its average volume of 1.00M shares. For investors focus on the performance of the stocks so the NAVI showed weekly ahead performance of 0.43% which was maintained for the month at -2.82%. Correspondingly the positive performance for the quarter was remained 12.82% and if took notice on yearly performance that was 58.42% whereas the year to date performance halted at 0.55%.
Millions of people resolve to improve their financial health at the starting of each year. Navient, the nation’s leading student loan servicer, celebrates its customers who started the new year on a path to financial success.
In 2016, more than 500,000 borrowers paid off their student loans. Elesea Russo of Fort Sumner, N.M. was one of them. Her repayment strategy included sticking to a budget, making on-time payments and paying extra whenever possible.
“I started out slowly,” she said. “At first my husband and I were just managing to pay each month’s minimum required payment. We targeted the smallest student loan and paid it off as quickly as possible, moving to the next smallest and so on until we paid off all of our combined student loans.”
Navient offers free tools and resources to assist borrowers improve their financial health. In 2016, Navient launched an additional 16 free resources online. They include a repayment calculator, newly added interactive videos, webcasts and a series on personal finance.
Mirati Therapeutics, Inc. (NASDAQ:MRTX), with shares fell -0.42% is now trading at $5.88. The Stock is active as 761,299.00 shares changed hands versus its average volume of 139,492.00 shares. The stock is going forward its 52 week low with 32.39% and lagging behind from its 52 week high price with - 80.46%. MRTX last month stock price volatility remained 6.76%.
Mirati Therapeutics, Inc. (MRTX) recently declared the pricing of an underwritten public offering of 4,350,176 shares of its common stock at a price to the public of $5.60 per share. In addition, and in lieu of common stock, Mirati is offering to funds associated with Boxer Capital, LLC pre-funded warrants to purchase up to an aggregate of 7,258,263 shares of common stock at a purchase price of $5.599 per warrant, which represents the per share public offering price for the common stock less the $0.001 per share exercise price for each such pre-funded warrant. The gross proceeds from this offering are predictable to be about $65.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Mirati. The offering is predictable to close on or about January 11, 2017, subject to customary closing conditions. Mirati has granted the underwriters a 30-day option to purchase up to an additional 652,526 shares of common stock in connection with the public offering. All of the securities are being offered by Mirati.
Mirati anticipates to use the net proceeds from this offering for general corporate purposes, counting for clinical development of glesatinib, sitravatinib and mocetinostat, in addition to for development of preclinical programs and working capital.
